Another Day, Another Record High and Who Knows Where It Will Go

NEW YORK (TheStreet) -- Another day, another closing all-time high in the DJIA and the S&P 500 on Monday, the first trading day in June. The DJIA closed up 26.46 points at 16743.63 while the S&P 500 closed up 1.40 at 1924.97. The Nasdaq finished down on the day at 4237.20 losing 5.40 points. The Russell 2000 index continued its losing ways, down 5.60 at 1128.90.

In many ways, the Russell 2000 index is the only index that is acting in a rational way. The economy is showing many "Growth Slowing" indicators and the Russell 2000 is a growth index. So, as the economy continues to slow the Russell 2000 index is in a Trend Bearish formation with many small caps stocks bearish. That is the way things are supposed to work.

Then you have the DJIA, S&P 500, and Nasdaq all in "Trend Bullish" formation. A two-tiered market, if you will. I have been mentioning this negative divergence for a while now but things do not seem to change. How long can we have a divergent stock market?

I do not have the answer to that question. But I suppose that as long as the Federal Reserve continues to print the money, the markets will continue to rise. I suspect the Fed will move to slow the taper of quantitative easing as the economy continues to show signs of slowing.

I am sure I am in the minority on this point. I expect the Fed to announce a slowing of the taper as we move forward in the summer months. If the Fed continues to taper that will lead to higher inflation and higher rates which will destroy the economy. If they continue printing money they will continue to burn the U.S. dollar and destroy the dollar hegemony.

If you liked this article you might like

How You Can Beat the Still Astronomical Prices for Prescription Drugs

Teva's Massive Debt Load Just Became an Even Bigger Issue

Teva Shares Are Getting Obliterated Again After Vicious Investment Bank Downgrades

Teva Shares Are Taking a Beating and Dragging Down the Generic Drugmakers

Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues